Decrease of the prevalence of helicobacter pylori infection in the Czech Republic;Pokles prevalence infekce Helicobacter pylori v České republice

Casopis Lekaru Ceskych

Volumn 147, Issue 5, 2008, Pages 255-257

  Bures J ^a   Kopacova M ^a   Rejchrt, S ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Decrease of prevalence; Helicobacter pylori

Indexed keywords

ARTICLE; CZECH REPUBLIC; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; PREVALENCE;

CZECH REPUBLIC; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; PREVALENCE;

EID: 44449168660     PISSN: 00087335     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Lehours, P., Yilmaz, O.: Epidemiology of Helicobacter pylori infection. Helicobacter, 2007, 12 (Suppl. 1), s. 1-3.
2. Magalhães Queiroz, D. M., Luzza, F.: Epidemiology of Helicobacter pylori infection. Helicobacter, 2006, 11 (Suppl. 1), s. 1-5.
3. Peura, D. A.: Bacteriology and epidemiology of Helicobacter pylori infection. UpToDate, vol. 15.3, Wellesley, 2007 (www.uptodate.com).
4. Blaser, M. J.: Hypothesis: the changing relationships of Helicobacter pylori and humans: implications for health and disease. J. Infect. Dis., 2000, 179, s. 1523-1530.
5. Linz, B., Balloux, F., Moodley, Y. et al.: An African origin for the intimate association between humans and Helicobacter pylori. Nature, 2007, 445, s. 915-918.
6. Yardley, J. H., Hendrix, T. R.: Acute and chronic gastritis due to Helicobacter pylori. UpToDate, vol. 15.3, Wellesley, 2007 (www.uptodate.com).
7. Blaser, M. J.: Helicobacter pylori: balance and imbalance. Eur. J. Gastroent. Hepatol., 1998, 10 (Suppl. 1), s. S15-S18.
8. Blaser, M. J., Atherton, J. C.: Helicobacter pylori persistence: biology and disease. J. Clin. Invest., 2004, 113, s. 321-333.
9. Sedláčková, M., Souček, A., Mucksová, J.: Serologická detekce protilátek proti Helicobacter pylori u dětí a dospívajících pomocí ELISA. Českoslov. Pediatr., 1992, 47, s. 577-580.
10. Fixa, B., Komárková, O.: Prevalence of Helicobacter pylori infection in various gastroduodenal disorders. Critical view on the basis of sufficient numbers of patients. Čs. Gastroenterol., 1993, 47, s. 57-58.
11. Fixa, B., Komárková, O., Melichar, B. et al.: Výskyt infekce Helicobacter pylori u české dospělé populace. Čes. Slov. Gastroent., 1995, 49, s. 83-85.
12. Mégraud, F., Bouchard, S., Brugmann, D. et al.: Seroprevalence of Helicobacter pylori infection in six countries of eastern Europe using common methodology. Gut, 1995, 37 (Suppl. 1), s. A71.
13. Sedláčková, M., Souček, A., Dohnalová, A.: Infekce Helicobacter pylori: shlukování v rodinách. Čas. Lék. čes., 1995, 134, s. 651-654.
14. Zelenková, J., Součková, A., Souček, A. et al.: Seroprevalence Helicobacter pylori u pražské populace. Čes. Slov. Gastroent., 1998, 52, s. 51-56.
15. Dítě, P., Hep, A., Dolina, J. et al.: Prevalence infekce Helicobacter pylori v ČR- region jižní Morava. Vnitř. Lék., 1998, 44, s. 132-134.
16. Bureš, J., Dítě, P., Kopáč ová, M. et al.: Prevalence of Helicobacter pylori in Czech Republic- preliminary data based on 13C-urea breath test in 389 symptom-free persons. Gut, 1999, 45 (Suppl. 5), s. A106.
17. Malaty, H., Sedláčková, M., Graham, D.Y. et al.: Helicobacter pylori infection in symptomatic and asymptomatic children in the Czech Republic. Gut, 2001, 49 (Suppl. 2), s. A80.
18. Sýkora, J., Varvařovská, J., Kuntschnerová , J. et al.: Symptomatologie a specifické rysy chronické gastritidy způsobené infekcí Helicobacter pylori v dětském věku v české populace- epidemiologicko-klinická, endoskopická a histomorfologická studie. Čas. Lék. čes., 2002, 141, s. 615-621.
19. Sedláčková, M., Malaty, H., Volf, V. et al.: Infekce Helicobacter pylori u souboru symptomatických a asymptomatických dětí a dospívajících v České republice. Čas. Lék. čes., 2003, 142, s. 102-105.
20. Bureš, J., Kopáčová, M., Koupil, I. et al.: Epidemiology of Helicobacter pylori infection in the Czech Republic. Helicobacter, 2006, 11,s. 56-65.
21. 13C: metodika vyšetření. Čas. Lék. čes., 2000, 139, s. 776-778.
22. Kopáčová, M., Bureš, J., Voříšek, V. et al.: Clinical use of mass spectrometry in Helicobacter pylori diagnostics. Reproducibility of the 13-C-urea breath test. Clin. Chem. Lab. Med., 2001,39, Suppl., s. 220.
23. Kopáčova, M., Bureš, J., Voří šek, V. et al.: Comparison of different protocols for (13)C-urea breath test for the diagnosis of Helicobacter pylori infection in healthy volunteers. Scand. J. Clin. Lab. Invest., 2005, 65, s. 491-498.
24. Malfertheiner, P., Megraud, F., O'Morain, C. et al.: Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut, 2007, 56, s. 772-781.
25. Kopáčová, M., Bureš, J., Koupil, I. et al.: Body indices and basic vital signs in Helicobacter pylori positive and negative persons. Eur. J. Epidemiol., 2007, 22, s. 67-75.
26. Kopáčová, M., Bureš, J., Koupilová, I. et al.: Prevalence of Helicobacter pylori infection in non-selected general population in Czech Republic. No birth-cohort phenomenon found in multicentre prospective study. Gut, 2002, 51, Suppl. 3, s. A108.
27. Sipponen, P.: Helicobacter pylori: a cohort phenomenon. Am. J. Surg. Pathol., 1995, 19 (Suppl. 1), s. S30-S36.
28. Šterzl, I., Hrdá, P., Matucha, P. et al.: Anti-Helicobacter pylori, anti-thyroid peroxidase, anti-thyroglobulin and anti-gastric parietal cells antibodies in Czech population. Physiol. Res., 2008, epub.
29. Jurgoš, L.: Infekcia Helicobacter pylori a funkčná dyspepsia - argumenty pre a proti. Postgrad. Med. (Praha), 2003, 5, s. 530-534.
30. Oona, M., Utt, M., Nilsson, I. et al.: Helicobacter pylori infection in children in Estonia: decreasing seroprevalence during the 11-year period of profound socioeconomic changes. Helicobacter, 2004, 9, s. 233-241.
31. Brown, L. M.: Helicobacter pylori: epidemiology and routes of transmission. Epidemiol. Rev., 2000, 22, s. 283-297.
32. O'Connor, H., Sebastian, S.: The burden of Helicobacter pylori infection in Europe. Aliment. Pharmacol. Ther., 2003, 18 (Suppl. 3), s. 38-44.
33. Rautelin, H., Kosunen, T. U.: Helicobacter pylori infection in Finland. Ann. Med., 2004, 36, s. 82-88.
34. Guslandi, M., Fanti, L., Testoni, P. A.: Helicobacter pylori seroprevalence in Crohn's disease: lack of influence by pharmacological treatment. Hepatogastroenterology, 2002, 49, s. 1296-1297.
35. Pronai, L., Schandl, L., Orosz, Z. et al.: Lower prevalence of Helicobacter pylori infection in patients with inflammatory bowel disease but not with chronic obstructive pulmonary disease- antibiotic use in the history does not play a significant role. Helicobacter, 2004, 9, s. 278-283.
36. Bateson, M. C.: Cigarette smoking and Helicobacter pylori infection. Postgrad. Med. J., 1993, 69, s. 41-44.
37. Brenner, H., Rothenbacher, D., Bode, G. et al.: Relation of smoking and alcohol and coffee consumption to active Helicobacter pylori infection: cross sectional study. Br. Med. J., 1997, 315, s. 1489-1492.
38. Moayyedi, P., Forman, D., Braunholtz, D. et al.: The proportion of upper gastrointestinal symptoms in the community associated with Helicobacter pylori, lifestyle factors, and nonsteroidal anti-inflammatory drugs. Leeds HELP Study Group. Am. J. Gastroent., 2000, 95, s. 1448-1455.
39. Rejchrt, S., Kopáčová, M., Koupil, I. et al.: Delta values of the 13C-urea breath test in Helicobacter pylori positive persons with and without dyspepsia. Folia Gastroenterol. Hepatol., 2004, 2, s. 105-110.
40. Rejchrt, S., Kopáčová, M., Koupil, I. et al.: Prevalence and socio-demographic determinants of uninvestigated dyspepsia in the Czech Republic. Eur. J. Gastroenterol. Hepatol., 2008 (v tisku).